IRIS
COLUSSI, Gian Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.360
EU - Europa 3.579
AS - Asia 1.863
SA - Sud America 369
AF - Africa 22
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 4
Totale 16.218
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.289
UA - Ucraina 1.114
SG - Singapore 941
IT - Italia 795
CN - Cina 569
DE - Germania 506
FI - Finlandia 368
BR - Brasile 348
RU - Federazione Russa 272
IE - Irlanda 195
TR - Turchia 122
SE - Svezia 111
KR - Corea 70
GB - Regno Unito 58
CA - Canada 54
FR - Francia 50
VN - Vietnam 48
BE - Belgio 23
HK - Hong Kong 20
EU - Europa 19
IN - India 19
AT - Austria 18
IR - Iran 16
CZ - Repubblica Ceca 14
NL - Olanda 14
BD - Bangladesh 12
AR - Argentina 11
MX - Messico 11
IQ - Iraq 7
JP - Giappone 7
PL - Polonia 7
ZA - Sudafrica 5
EE - Estonia 4
EG - Egitto 4
MA - Marocco 4
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
CO - Colombia 3
DK - Danimarca 3
ES - Italia 3
JO - Giordania 3
PK - Pakistan 3
RO - Romania 3
TG - Togo 3
TN - Tunisia 3
UZ - Uzbekistan 3
AM - Armenia 2
BT - Bhutan 2
CL - Cile 2
DZ - Algeria 2
HN - Honduras 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
LV - Lettonia 2
ME - Montenegro 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
QA - Qatar 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 16.218
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.428
Fairfield 1.110
Ann Arbor 912
Jacksonville 796
Chandler 594
Houston 573
Ashburn 535
Singapore 507
Dearborn 501
Wilmington 494
Seattle 453
Cambridge 370
Boardman 282
Beijing 255
Princeton 217
Dublin 193
Udine 150
Izmir 107
San Diego 83
Seoul 60
Des Moines 48
Ogden 48
Dong Ket 47
Hefei 44
Norwalk 44
Redmond 42
Milan 40
Ottawa 40
Nanjing 37
Rome 32
San Mateo 32
Kunming 30
Guangzhou 25
Los Angeles 25
Nuremberg 25
Helsinki 24
Brussels 23
São Paulo 21
Hong Kong 20
Trieste 19
Munich 18
New York 15
Santa Clara 15
Shanghai 14
Mcallen 13
San Francisco 13
Vienna 13
Belo Horizonte 12
Brno 12
Grafing 12
Falls Church 11
Washington 11
Jinan 10
Bologna 9
Düsseldorf 9
Fuzhou 9
London 9
Phoenix 9
Pignone 9
Rio de Janeiro 9
Turin 9
Vicenza 9
Council Bluffs 8
Espoo 8
Frankfurt am Main 8
Indiana 8
Wuhan 8
Brooklyn 7
Ferrara 7
Goiânia 7
Ankara 6
Boston 6
Hangzhou 6
Hebei 6
Leawood 6
Nanchang 6
Tavagnacco 6
Torre Del Greco 6
Warsaw 6
Zhengzhou 6
Ancona 5
Castellammare Di Stabia 5
Changsha 5
Henderson 5
Mumbai 5
Palermo 5
Paris 5
Porto Alegre 5
Saint Petersburg 5
Simi Valley 5
Tokyo 5
Toronto 5
Turku 5
Uberlândia 5
Venezia 5
Venice 5
Verona 5
Xian 5
Zanjan 5
Andover 4
Totale 10.756
Salva come PNG Salva come JPEG
Nome #
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 244
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 171
Aldosterone and the heart: from basic research to clinical evidence 156
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 153
Aldosterone and Left Ventricular Remodeling 148
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 144
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 135
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 135
The emergent cardiovascular risk factors and organ damage in arterial hypertension 133
Aldosterone and the heart: still an unresolved issue? 133
Aldosterone, Organ Damage, and Dietary Salt 131
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 129
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 128
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 127
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 126
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 126
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 125
Treatment of primary aldosteronism and organ protection 125
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 124
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 123
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 123
Benzodiazepines: an old class of new antihypertensive drugs? 120
Kidney in primary aldosteronism: a key determinant of treatment outcome 119
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 119
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 117
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 117
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 116
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 115
Salt, hypertension, and cardiovascular disease 114
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 114
Glucocorticoid-induced leucine zipper protein regulates sodium and potassium balance in the distal nephron 114
Renal function in primary aldosteronism 113
Potassium-sparing diuretics in hypertension 113
Cardiovascular outcomes in patients with primary aldosteronism after treatment 113
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 112
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 111
Omega-3 Polyunsaturated Fatty Acids in the Treatment of Non-Alcoholic Fatty Liver Disease: Are They So Good? 110
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 109
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 109
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 108
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 108
Diabetes, diabetic complications, and blood pressure targets 108
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 107
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 107
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 107
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 105
Hypertension and type 2 diabetes: lights and shadows about causality 105
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 102
Insulin sensitivity in patients with primary aldosteronism: a follow-up study 101
The Rising Burden of Hypertensive Renal Disease in Low-Income Countries: Is it Time to Take Action? 101
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 101
Renal cysts and hypokalemia in primary aldosteronism: results of long-term follow-up after treatment 100
Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients 100
Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment 99
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 99
Uricaemia and left ventricular mass in hypertensive patients 99
Subclinical carotid artery disease and plasma homocysteine levels in patients with hypertension 99
Plasma glucose levels and left ventricular diastolic function in nondiabetic hypertensive patients 98
Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era 97
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients: Response to Perciaccante et al. [4] 97
Associazione dell’ispessimento miointimale carotideo con uno stato protrombotico in pazienti ipertesi 96
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 96
Plasma lipoprotein(a) levels and atherosclerotic renal artery stenosis in hypertensive patients 95
Response to "plasma Homocysteine Levels and Endothelial Dysfunction in Cerebro-and Cardiovascular Diseases in the Metabolic Syndrome" 95
Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients 95
Relationships of plasma renin with renal function in primary aldosteronism: revisiting the concept of renin escape 94
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 93
Omega-3 polyunsaturated fatty acids in blood pressure control and essential hypertension 92
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 92
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 92
Association of elevated levels of PAI-1 with insulin resistance and inflammatory markers in hypertension. 91
The carotid intima-media thickness and cardiac tissue Doppler in hypertension 90
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 90
Hyperaldosteronism and Left Ventricular Hypertrophy 89
Studio della funzione endoteliale in pazienti con steatosi epatica non-alcolica. 88
Ambulatory blood pressure and left ventricular geometry in patients with myotonic dystrophy 87
Alpha-adducin gene polymorphism predicts cardiac and vascular response to treatment in hypertensive women 87
Mineralocorticoid Antagonists Treatment Versus Surgery in Primary Aldosteronism 87
Effects of renal revascularization on renal and cardiac function in hypertensive patients 86
Effects of n-3 polyunsatured fatty acids (PUFA) on markers of oxidative stress in hypertension 84
Association of a prothrombotic state with carotid intima-media thickness in hypertensive patients 83
Novel role for SGK3 in glucose homeostasis revealed in SGK3/Akt2 double-null mice 83
Functioning or Non-Functioning Adrenal Adenoma? Probably, Just a Matter of Time 82
The new cardiovascular risk factors in hypertensive patients with metabolic syndrome 82
Predictive factors of left ventricular mass changes after treatment of primary aldosteronism 81
Ipertensione arteriosa e poliglobulia in paziente con stenosi multiple delle arterie renali 80
Metabolic Dysfunction in Primary Aldosteronism 80
Cardiac and renal damage in primary aldosteronism 78
Renal function in primary aldosteronism: revisiting the concept of “renin escape” 78
Association of a prothrombotic state with the metabolic syndrome in essential hypertensive patients 77
Plasma aldosterone levels are related to urinary albumin excretion in hypertensive patients 77
ω-3 Polyunsaturated Fatty Acids Effects on the Cardiometabolic Syndrome and their Role in Cardiovascular Disease Prevention: An Update from the Recent Literature 77
Association of a prothrombotic state with left-ventricular diastolic dysfunction in hypertension: a tissue-Doppler imaging study 76
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 76
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3Kgamma 75
Endothelial function in patients with non-alcoholic fatty liver disease 74
Aldosterone and aldosterone antagonists in cardiac disease: what is known, what is new 74
Intima-media thickness and left ventricular dysfunction: a Tissue-Doppler echocardiographic study 73
Reversal of left ventricular hypertrophy after treatment is related to severity of disease in patients with primary aldosteronism 73
La lipoproteina(a) come fattore di rischio cardiovascolare: una revisione delle conoscenze attuali 72
Totale 10.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.864
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020276 0 0 0 0 0 0 0 0 0 0 0 276
2020/20212.441 69 243 68 315 79 333 136 278 411 81 292 136
2021/20221.596 76 182 64 125 47 55 85 96 22 256 307 281
2022/20231.649 251 95 31 184 139 486 6 92 234 24 55 52
2023/2024520 91 32 41 9 82 58 23 12 70 20 8 74
2024/20252.586 80 265 141 116 72 155 173 186 415 294 638 51
Totale 16.801